Key Takeaways for CAVA Stock as of August 2026
- Q2 Beat: CAVA grew Q2 revenue 31.3% YoY to $365.4M, with same restaurant sales up 9% on 5.3% traffic growth, and adjusted EBITDA rose 30% YoY to $54.7M.
- Guidance Held: CAVA reiterated its full year outlook despite a Cyclospora-driven sales dip in July.
- Cash Flow Streak: CAVA logged its 10th straight quarter of positive free cash flow, with YTD free cash flow reaching $44.8M and operating cash flow climbing to $134.5M from $98.9M a year earlier, and it carries zero debt against $435.6M in cash and investments.
- CFO’s Confidence: CFO Tricia Tolivar said same restaurant sales have already rebounded to the mid-single digits, noting “there’s nothing in what we’re seeing in our trends today that would suggest we would land at the lower end of the range.”
CAVA Posts 9% Comps and Holds Guidance Through a Food Safety Scare
CAVA Group (CAVA) grew second quarter 2026 revenue 31.3% year over year to $365.4 million, a print that arrived alongside a same restaurant sales gain of 9% built on 5.3% traffic growth. The quarter closed just as a Cyclospora outbreak tied to imported produce rattled the fast-casual industry, and CAVA felt the aftershock even though it does not source leafy greens from Mexico or serve iceberg lettuce on its menu.
The company opened 17 net new restaurants in the quarter, ending with 476 locations across 29 states, a 19.6% increase from a year earlier. New unit productivity stayed above 100% of system average, and system-wide average unit volumes reached $3.1 million, evidence that CAVA’s expansion into markets like Indiana and Ohio is not diluting the model ahead of planned entries into Las Vegas and the Bay Area.
Restaurant-level profit climbed 28.1% to $93.8 million, but the margin rate slipped to 25.7% of revenue from 26.3% a year ago. Food, beverage, and packaging costs rose 50 basis points to 30% of revenue on input costs tied to the nationwide launch of Pomegranate Glazed Salmon, and labor costs rose 30 basis points to 25.3% on a 3% wage investment. Occupancy leverage cut the other way, improving 50 basis points to 6.3% of revenue. Adjusted EBITDA still rose 30% to $54.7 million, net income reached $23 million against $18.4 million a year earlier, and diluted EPS climbed to $0.19 from $0.16.
That earnings power showed up in cash generation. CAVA posted its 10th consecutive quarter of positive free cash flow, with the year-to-date figure at $44.8 million and operating cash flow up to $134.5 million from $98.9 million. The balance sheet carries zero debt against $435.6 million in cash and investments.
Sales trends dipped toward flat as the Cyclospora outbreak spread in July, then improved sequentially each week. CFO Tricia Tolivar addressed the recovery directly on the Q2 earnings call: “If you look at guidance to deliver on the low end of the range, it would be slightly negative same restaurant sales. The upper end of the range would be in the mid-single-digit range. There’s nothing in what we’re seeing in our trends today that would suggest we would land at the lower end of the range.” Management reiterated full year guidance for 75 to 77 net new restaurants, same restaurant sales of 4.5% to 6.5%, restaurant-level margin between 23.7% and 24.3%, and adjusted EBITDA of $181 million to $191 million.
TIKR Values CAVA Stock at $212, Pricing In a Full Recovery From the Cyclospora Scare
TIKR’s mid-case model values CAVA stock at $212 by December 2030, implying 248% total return from the current price of $61, or 33% annualized over 4.4 years.
That annualized return sits well above what investors typically demand from a mature restaurant operator, reflecting the model’s expectation that CAVA’s unit growth and margin recovery compound faster than the broader category for years to come.
The target is reachable because the Cyclospora disruption never touched CAVA’s underlying demand: same restaurant sales already climbed back to mid-single digits, new restaurant productivity held above 100%, and the loyalty base is growing faster than store count. With guidance intact and expansion into Las Vegas and the Bay Area still ahead, the growth drivers behind the model’s 33% annualized return remain in place.
Should You Invest in CAVA Group, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up CAVA Group, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track CAVA Group, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze CAVA stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
